We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Great Potential of Quantum Dot Imaging

By Biotechdaily staff writers
Posted on 10 Feb 2005
The development of nanocrystals known as quantum dots over the past 20 years has evolved into a new method that allows scientists to study cell processes at the level of an individual molecule, and may result in better ways to detect and treat cancers.

Semiconductor fluorescent quantum dots, called qdots, also have potential for high-resolution cellular imaging and the long-term study of single molecules and their movement within cells, according to researchers at the University of California, Los Angeles (UCLA; CA, USA) and Stanford University (Palo Alto, CA, USA). More...
The investigators published their work in the January 28, 2005, issue of the journal Science.

Qdot imaging is a new way to see biologic processes functioning within cells and in small animals. Probes can be attached to a specific protein or receptor to track it and see what other molecules it interacts with, what areas of the cell it is in, and what signaling pathways the protein may use for performing typical cell functions and abnormal functions that may result in cancer. Because qdots are nanocrystals--minuscule bits of rock one-billionth of a meter in size--they provide excellent contrast for imaging with an electron microscope.

The UCLA investigators believe that qdots might be utilized one day to do two things--diagnose and treat cancer. The technology will enable investigators to find a tumor within the body, look at it very specifically at the cellular level to determine what kind of cancer it is, and then maybe arm it with therapies developed to kill the disease.

Qdots have so much potential because they can be color-coded, with different colors utilized to label different cell mechanisms, different cancers, or different stages of the same cancer. At present, a positron emission tomography (PET) scan can tell clinicians the sites of tumors throughout the body, based on targeting the PET probe to an individual tumor marker. However, with qdots, several different markers of the same tumor could be simultaneously "painted,” producing a color barcode for real-time optical biopsy and diagnosis.

In the study, qdots were labeled with a positron-emitting isotope and injected into mice. Utilizing a PET scanner, scientists were able to watch over time as the qdots traveled through the vascular system and to the liver. The same technique may be used with patients, who could be injected with a mixture of different colored qdots that would label the cancer cells. Once they accumulate at the tumor site, the positrons emitted from the qdots could be imaged with PET scanners.






Related Links:
University of California, Los Angeles

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Urinalysis Solution
UN-9000
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.